DEFA14A ·Filed Mar 12, 2026
Proxy solicitation materials
Actionable Insight • Neutral
This is a routine annual meeting notice. No immediate action is required beyond reviewing the proxy materials and voting on the proposals. The outcome of the director elections and the shareholder proposal are the only items with potential, though minimal, market impact.
Final — all horizons settled through T+60d
WST ▲ +36.25% at T+60d
NEUTRAL call ✓ call won +36.25% · α vs SPY +25.55% · entry $230.82 → $314.50
T+1d
+1.88%
call +1.88% · α +2.48%
$235.16
settled 7mo ago
T+5d
+4.00%
call +4.00% · α +4.98%
$240.05
settled 7mo ago
T+20d
+10.96%
call +10.96% · α +8.99%
$256.12
settled 6mo ago
T+60d
+36.25%
call +36.25% · α +25.55%
$314.50
settled 4mo ago
Price Chart
Loading chart...
Executive Summary
Analysis based on filing metadata only — document content was unavailable
Key Facts
- Filing is a DEFA14A (Definitive Additional Materials) for West Pharmaceutical Services, Inc.
- It is a proxy statement for the 2026 Annual Meeting.
- The meeting will be held virtually on May 4, 2026.
- Proposals include the election of 11 directors, an advisory vote on executive compensation, ratification of the independent auditor, and a shareholder proposal on an independent board chair.
Financial Impact
No financial impact from this filing.
Risk Factors
- The shareholder proposal for an independent board chair could signal governance concerns if it receives significant support, though it is opposed by management.
Market Snapshot
Exchange
NYSE
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001104659-26-026779 |
| Document: 0001104659-26-026779-index-headers.html | 0001104659-26-026779 |
| Document: 0001104659-26-026779-index.html | 0001104659-26-026779 |
| Document: 0001104659-26-026779.txt | 0001104659-26-026779 |
12 reports for WST
50% Hit rate best @ T+60▲ +16.33%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 23, 2026 10w ago | 8-K | $355.48 $353.77 | ▼ −0.48% | ▼ −3.79% | $364.89 (+2.65%) |
Jul 23, 2026 10w ago | Press Release | $355.48 $353.77 | ▼ −0.48% | ▼ −3.79% | $364.89 (+2.65%) |
Jul 7, 2026 12w ago | Press Release | $356.08 $347.94 | ▼ −2.29% | ▼ −3.62% | $364.89 (+2.47%) |
May 11, 2026 20w ago | 8-K | $311.82 $330.92 | ▼ −6.12% | ▼ −7.85% | $364.89 (−17.02%) |
Apr 27, 2026 22w ago | Insider Cluster | $300.93 $316.17 | ▲ +5.06% | ▲ +0.11% | $364.89 (+21.25%) |
Apr 27, 2026 22w ago | Insider Cluster | $300.93 $316.17 | ▲ +5.06% | ▲ +0.11% | $364.89 (+21.25%) |
Apr 27, 2026 22w ago | Insider Cluster | $300.93 $316.17 | ▲ +5.06% | ▲ +0.11% | $364.89 (+21.25%) |
Apr 27, 2026 22w ago | Insider Cluster | $300.93 $316.17 | ▲ +5.06% | ▲ +0.11% | $364.89 (+21.25%) |
Apr 27, 2026 22w ago | Insider Cluster | $300.93 $316.17 | ▲ +5.06% | ▲ +0.11% | $364.89 (+21.25%) |
Apr 27, 2026 22w ago | Insider Cluster | $300.93 $316.17 | ▲ +5.06% | ▲ +0.11% | $364.89 (+21.25%) |
Showing 10 of 12
US Market Status
Market Closed — Opens Mon (65h 29m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access